Form 4: Semler Scientific Director William H. Chang Acquires 27,000 Stock Options

Director William H. Chang acquired 27,000 stock options in Semler Scientific, Inc. as part of non-employee director compensation.

Summary

• William H. Chang, a director of Semler Scientific, Inc., acquired 27,000 stock options on May 24, 2024.
• The options were granted as non-employee director compensation for his appointment to a newly formed committee of the board.
• The exercise price of the stock options is $23.32.
• 1/24th of the underlying shares vested immediately on the grant date, with the remainder vesting monthly until April 24, 2026.
• The stock options expire on May 24, 2026.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock option grant) for director compensation, which is generally viewed neutrally to positively as it aligns interests. There are no indications of negative sentiment.

Positives

• The acquisition of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes the director to remain engaged with the company over the long term.

Future Outlook

NA

Industry Context

This is a standard practice for compensating non-employee directors, aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Granting stock options to non-employee directors is a common practice among publicly traded companies to incentivize board members and align their interests with shareholders.
• The vesting schedule of these options, with monthly vesting until April 2026, is fairly standard and encourages long-term engagement.
• Comparable companies in the medical device or diagnostics industry often use similar compensation packages for their directors.

Stakeholder Impact

• The granting of stock options to a director can positively impact shareholders by aligning the director's interests with the company's long-term success.

Key Dates